Is a complete ASX/BIO research report available?

No complete published report is available for asx/BIO (ASX/BIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

asx/BIO stock profile: metrics, valuation and analysis

Market cap	84.4M
Revenue (ttm)	23.9M
Net income (ttm)	3.6M
EPS (ttm)	A$0.02
Shares out	228M
P/E (trailing)	23.3x
P/E (forward)	23.1x
Volume	16,600
Beta	0.99

All ASX/BIO indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

AUD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	30
Employees Change	0%
Employees Change Percent	0
Enterprise value	AUD 83.8M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Packaged Foods
Industry PE Fwd	16.28
Isin	AU0000184137
Last refreshed	2026-09-11
Market cap	AUD 84.4M
Price	AUD 0.37
Price currency	AUD
Sector	Consumer Staples
Sector PE	90.72
Sector PE Fwd	21.86
Sic	2833
Symbol	asx/BIO
Website	https://www.biomeaustralia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.28%
EV Earnings	23.22x
EV/EBIT	143.76x
EV/EBITDA	89.6x
EV/FCF	58.89x
EV/Sales	3.51x
FCF yield	1.69%
Forward P/E	23.13x
P/B ratio	8.99x
P/E ratio	23.27x
P/S ratio	3.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.44%
EBITDA Margin	3.08%
FCF margin	5.96%
Gross margin	57.45%
Gross Profit	AUD 13.7M
Gross Profit Growth	35.65%
Gross Profit Growth Q	30.48%
Gross Profit Growth3 Y	47.5%
Gross Profit Growth5 Y	63.37%
Net Income	AUD 3.6M
Net Income Growth	1,580.93%
Net Income Growth Qo Q	106.65%
Net Income Growth Quarters	2%
Net Income Growth Years	5%
Pretax Margin	4.97%
Profit Margin	15.11%
Profitable Quarters	AUD 2
Profitable Years	2
ROA	2.63
Roa5y	-19.07
ROCE	5.68
ROE	51.34
Roe5y	-33.48
ROIC	3.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.93%
Cagr3y	39.93%
EPS Growth	1,519
EPS Growth Qo Q	105.4
EPS Growth Quarters	2
EPS Growth Years	5
Revenue Growth	29.68x
Revenue Growth Q	20.21x
Revenue Growth Qo Q	-7.39x
Revenue Growth Quarters	14x
Revenue Growth Years	7x
Revenue Growth3 Y	48.89x
Revenue Growth5 Y	59.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 1.73
Assets	AUD 15.7M
Cash	AUD 3.6M
Current Assets	AUD 11.6M
Current Liabilities	AUD 5.5M
Debt	AUD 3M
Debt EBITDA	AUD 3.17
Debt Equity	AUD 0.32
Debt FCF	AUD 2.09
Equity	AUD 9.4M
Interest Coverage	5.09
Liabilities	AUD 6.3M
Long Term Assets	AUD 4.2M
Long Term Liabilities	AUD 883,402
Net Cash	AUD 583,199
Net Cash By Market Cap	AUD 0.69
Net Debt EBITDA	AUD -0.79
Net Debt Equity	AUD -0.06
Net Debt FCF	AUD -0.41
Tangible Book Value	AUD 8.9M
Tangible Book Value Per Share	AUD 0.04
WACC	9.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.12
Inventory Turnover	2.51
Net Working Capital	AUD 4.7M
Quick ratio	1.34
Working Capital	AUD 6.1M
Working Capital Turnover	AUD 4.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.92%
200-day SMA	0.34
3Y total return	174.07%
50-day SMA	0.29
50-day SMA vs 200-day SMA	50under200
All Time High	0.87
All Time High Change	-57.47%
All Time High Date	2024-09-20
All Time Low	0.06
All Time Low Change	516.67%
All Time Low Date	2023-06-08
ATR	0.02
Beta	0.99
Beta1y	0.97
Beta2y	0.99
Ch YTD	-11.9
High	0.37
High52	0.53
High52 Date	2025-10-02
High52ch	-30.48%
Low	0.36
Low52	0.2
Low52 Date	2026-06-02
Low52ch	82.5%
Ma50ch	28.03%
Price vs 200-day SMA	8.47%
RSI	66.38
RSI Monthly	49
RSI Weekly	59
Sharpe ratio	-0.13x
Sharpe Ratio3y	0.79x
Sortino ratio	-0.12
Sortino Ratio3y	1.42
Total Return	-1.12%
Tr YTD	-11.9
Tr1m	27.59%
Tr1w	13.85%
Tr3m	37.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	150,723,759%
Net Borrowing	-1,212,329
Shares Insiders	26.3%
Shares Institutions	1.05%
Shares Out	227,998,033
Shares Qo Q	0.81%
Shares Yo Y	1.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD 1.1M
Adjusted OCF	1,280,441
Average Volume	267,986.55x
Bv Per Share	0.04
CAPEX	AUD -204,376
Ch1m	27.59
Ch1w	13.85
Ch1y	-22.92
Ch3m	37.04
Ch3y	174.1
Ch6m	-7.5
Change	-1.35%
Change From Open	-1.35
Close	0.37
Days Gap	0
Depreciation Amortization	152,385
Dollar Volume	6,059
Earnings Date	2026-11-20
EBIT	AUD 582,766
EBITDA	AUD 735,151
EPS	AUD 0.02
F Score	5
FCF	AUD 1.4M
FCF EV Yield	1.7x
FCF Per Share	AUD 0.01
Financing CF	-333,484
Fiscal Year End	June
Founded	2,018
Graham Number	0.12131
Graham Upside	-67.21
Income Tax	AUD -2.4M
Investing CF	-488,706
Is Primary Listing	1
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Ma150	0.31
Ma150ch	18.55%
Ma20	0.31
Ma20ch	17.72%
Net CF	804,759
Next Earnings Date	2026-11-20
Open	0.37
P FCF Ratio	59.3
P FCF Ratio SBC	78.4
P OCF Ratio	51.85
P OCF Ratio SBC	65.88
Position In Range	66.67
Ppne	1,282,462
Price Date	2026-09-11
Price EBITDA	AUD 115
Ptbv Ratio	9.44
Relative Volume	0.06x
Revenue	23,883,240x
SBC By Revenue	1.45x
Share Based Comp	346,508
Tax By Revenue	-10.14x
Tr6m	-7.5%
Volume	16,600
Z Score	9.55

ASX/BIO (ASX/BIO)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/BIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/BIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ASX/BIO

Frequently asked questions